USPTO 2015–2025 USPTO PatentsView US Corporation

10x Genomics, Inc.

USPTO PatentsView assignee record - 373 granted patents across 35 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

373

Total patents granted

CPC technology areas

26.5

Avg claims per patent

+478%

5-year filing velocity

The verdict

10x holds 373 US patents across 35 technology areas, rank #1,132 of 50,000 tracked assignees.

#1,132
of 50,000 US assignees by volume: Top 1%
by Innovation Score (68.9/100): 26.5
avg claims per patent: +478%
filing velocity, last 5 yrs

Portfolio overview

10x Genomics, Inc. has been granted 373 US utility patents between 2016 and 2025, placing 10x Genomics, Inc. at rank #1,132 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 26.5 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, 10x Genomics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, 10x sits between Mercedes-benz Group Ag (375 patents, rank #1,128) and Samsung SDS Co., Ltd. (372 patents, rank #1,136) - the closest US assignees by grant volume. The composite Innovation Score of 68.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 318 grants, compared with 55 in the 2015–2019 window, a +478% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. 10x Genomics, Inc.'s 26.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 10x Genomics, Inc. against peers pursuing similar technology classes.

Mercedes-benz Gro…

375
TE Connectivity G…

375
Anthura B V

374
MAKO Surgical

374
Huawei Digital Po…

373
Nokia

373
University of Bri…

373
10x Genomics ◀

373
Samsung SDS

372

What this shows 10x holds 373 patents at rank #1,132, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 10x

By rank, the assignees closest to #1,132 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in 10x's primary technology class.

10x's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

69 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

10x Genomics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	1.1%
2017	7	1.9%
2018	15	4.0%
2019	29	7.8%
2020	41	11.0%
2021	22	5.9%
2022	29	7.8%
2023	62	16.6%
2024	82	22.0%
2025	82	22.0%

Which technologies does 10x Genomics, Inc. patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 282

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 137

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 89

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 59

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 37

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 37

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 21

G06F - ELECTRIC DIGITAL DATA PROCESSING 19

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 17

C07K - PEPTIDES 15

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 12

C12Y - ENZYMES 12

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 9

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 9

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 9

Top 15 of 35 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#1,132

Across all tracked assignees

Innovation Score

68.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does 10x Genomics, Inc. hold?

10x Genomics, Inc. holds 373 US granted patents filed between 2016 and 2025, spanning 35 technology areas.

What is 10x Genomics, Inc.'s Innovation Score?

10x Genomics, Inc. has an Innovation Score of 68.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 10x Genomics, Inc. focus on?

10x Genomics, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 282 patents. The company has filed patents in 35 CPC subclasses total.

Is 10x Genomics, Inc.'s patent filing rate increasing or decreasing?

10x Genomics, Inc.'s recent filing velocity is +478% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for 10x Genomics, Inc.'s patents?

10x Genomics, Inc.'s patents average 26.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the 10x Genomics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

10x's 373 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - 10x ranks #1,132 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.